50
Participants
Start Date
October 26, 2016
Primary Completion Date
May 31, 2018
Study Completion Date
August 30, 2018
PF-06480605
PF-06480605 500 mg IV Q2W x 7 Doses
UZ Leuven (University Hospital Leuven) - Pharmacy Clinical Trials, Leuven
UZ Leuven (University Hospital Leuven) - Radiology Department, Leuven
UZ Leuven (University Hospital Leuven), Campus Gasthuisberg, Leuven
New York Presbyterian Hospital-Weill Cornell Medical College, New York
Weill Cornell Medical College, New York
Weill Cornell Medicine, New York
New York Presbyterian Hospital, New York
NYU Langone Long Island Clinical Research Associates, Great Neck
NYU Langone Nassau Gastroenterology Associates, Great Neck
ISTITUTO CLINICO HUMANITAS Sezione Autonoma di Malattie Infiammatorie Croniche Intestinali, Rozzano
FQL Research, LLC, Pembroke Pines
Venture Ambulatory Surgical Center, North Miami Beach
Surgery Center of Aventura, Aventura
Allegiance Research Specialists, LLC, Wauwatosa
"AOU Mater Domini - Univ.Magna Graecia di Catanzaro - Campus Venuta - U.O Fisiopatologia Digestiva", Catanzaro
Brigham and Women's Hospital, Boston
Brigham and Women's Hospital, Chestnut Hill
Policlinico Universitario Campus Biomedico, Roma
Academic Medical Center, Apotheek-Kenniscentrum Geneesmiddelenonderzoek, Amsterdam
Academic Medical Centre, Department of Radiology, Amsterdam
Academic Medical Centre, Dept. of Gastroenterology, Amsterdam
SPZOZ WSzZ im. Jedrzeja. Sniadeckiego W Bialymstoku Oddzial Chorob Wewnetrznych i Gastroenterologii, Bialystok
Centrum Endoskopii Zabiegowej, Poradnia Chorob Jelitowych Szpital Uniwersytecki nr 2 im Jana Biziela, Bydgoszcz
Piotr Walczak Gabinet Endoskopii Przewodu Pokarmowego, Krakow
SANTA FAMILIA Centrum Badan Profilaktyki i Leczenia, Lodz
Endoskopia Sp. z.o.o., Sopot
Kangbuk Samsung Hospital, Seoul
Asan Medical Center, Seoul
Collaborators (1)
Pfizer
INDUSTRY
Telavant, Inc.
INDUSTRY